Calcitonin Gene-Related Peptide Monoclonal Antibody Treatment in Nine Cases of Persistent Headache Following COVID-19-Infection
CGRP mAbs may be considered a potential treatment option for persistent headaches following COVID-19, especially the long-COVID headaches. Their use may contribute to an improved burden of headache and quality of life and may help alleviate the psychological symptoms associated with persistent headaches.
Authors
- Yooha Hong (ORCID: https://orcid.org/0000-0002-8693-2831)
- Mi‐Kyoung Kang (ORCID: https://orcid.org/0000-0001-7260-3984)
- Soyoun Choi (ORCID: https://orcid.org/0000-0002-9581-778X)
- Soo‐Jin Cho (ORCID: https://orcid.org/0000-0002-4053-3763)
- Tae‐Jin Song (ORCID: https://orcid.org/0000-0002-9937-762X)
Institutions
- Ewha Womans University (KR)
- Hallym University Dongtan Sacred Heart Hospital (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3346/jkms.2025.40.e127
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ewha Womans University
- Hallym University
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
- Ministry of Science and ICT, South Korea
- Korea Evaluation Institute of Industrial Technology
- Institute for Information and Communications Technology Promotion